BioSpace News Archive

Hepion Pharmaceuticals, Inc. announced that a study of Hepion’s CRV431 conducted by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, demonstrated positive antiviral activity against SARS coronavirus-2.

Dogma Therapeutics (“Dogma”), a Viva Biotech Portfolio Company, has reached an agreement for the acquisition of its oral PCSK9 program by AstraZeneca. Dogma will receive upfront as well as downstream payments linked to global regulatory and commercial milestones. The pursuit of a convenient, oral PCSK9-based therapy has bee

- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces that the Company will host its earnings conference call on Friday, September 25, 2020 at 8:00 am Eastern Time (5:00 am Pacific Time/ 8:00 pm Beijing Time) to discuss the Company’s financial results of the second quarter ended June 30, 2020. To attend this earnings conference call, p

Dyadic International, Inc. today announced collaboration with Jiangsu Hengrui Medicine Co., Ltd. (“Hengrui”) (SSE:600276) to apply Dyadic’s C1 technology to the development of selected Hengrui biologic drug(s).

21 winning teams selected to receive funding for innovative solutions to most pressing issues caused by pandemic

Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces its and the University of Louisville’s joint filing of a United States provisional patent application, entitled “Methods of inhibiting or treating coronavirus infection, and methods for delivering an anti-nucleolin agent.”

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the publication of a new real-world post-marketing surveillance study in Pain Medicine that demonstrates the safety, efficacy and consistency of the company’s Nerivio® therapeutic wearable device.

New DNA-based test detects most frequent fungal organisms that cause Ringworm in variety of companion animals; confirmatory dermatophyte culture available from same sample

Neurogene Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by neurological diseases, today announced Robert A. Baffi, Ph.D. will join its board of directors.

Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, announced today the completion of initial vaccination of the first dose cohort in the Phase 1 healthy volunteer study of V-306,